Canopy Growth Files 8-K with Key Disclosures

Ticker: CGC · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1737927

Canopy Growth Corp 8-K Filing Summary
FieldDetail
CompanyCanopy Growth Corp (CGC)
Form Type8-K
Filed DateAug 29, 2025
Risk Levelmedium
Pages5
Reading Time6 min
Key Dollar Amounts$200,000,000, $50,000,000
Sentimentneutral

Sentiment: neutral

Topics: disclosure, financials, regulation-fd

TL;DR

Canopy Growth dropped an 8-K on 8/29 - check it for Reg FD, other events, and financials.

AI Summary

Canopy Growth Corporation filed an 8-K on August 29, 2025, reporting on events that occurred on the same date. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located at 1 Hershey Drive, Smiths Falls, Ontario, K7A 0A8.

Why It Matters

This 8-K filing provides important updates and disclosures from Canopy Growth Corporation, which could impact investor understanding of the company's current status and future outlook.

Risk Assessment

Risk Level: medium — 8-K filings can contain material information that significantly impacts a company's stock price and investor decisions.

Key Players & Entities

  • Canopy Growth Corporation (company) — Registrant
  • August 29, 2025 (date) — Date of earliest event reported
  • 1 Hershey Drive Smiths Falls , Ontario K7A 0A8 (address) — Principal executive offices
  • 001-38496 (company_id) — Commission File Number

FAQ

What specific events are being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.

What are the 'Other Events' being reported by Canopy Growth?

The filing lists 'Other Events' as an item information category, but the specific nature of these events is not detailed in the provided text.

What financial statements and exhibits are included in this 8-K filing?

The filing states that 'Financial Statements and Exhibits' are included, but the content of these documents is not specified in the provided text.

When was Canopy Growth Corporation incorporated, and in which jurisdiction?

Canopy Growth Corporation is incorporated in 'Canada', as stated in the filing.

What is the primary business of Canopy Growth Corporation?

Based on the Standard Industrial Classification code [2833], Canopy Growth Corporation is in the 'Medicinal Chemicals & Botanical Products' industry.

Filing Stats: 1,517 words · 6 min read · ~5 pages · Grade level 12.3 · Accepted 2025-08-29 17:03:52

Key Financial Figures

  • $200,000,000 — to an aggregate offering price of up to $200,000,000 of the Company's common shares (the "Co
  • $50,000,000 — ggregate gross sales proceeds exceeding $50,000,000 (the "Canadian Cap") and (ii) in no eve

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On August 29, 2025, Canopy Growth Corporation (the "Company") issued a press release announcing its new at-the-market equity program, which is attached as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated herein by reference. The information in Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act"), or otherwise be incorporated by reference into any filing under the Securities Act of 1933, as amended (the "Securities Act") or the Exchange Act, regardless of any incorporation by reference language in any such filing.

01. Other Events

Item 8.01. Other Events. On August 29, 2025, the Company entered into an equity distribution agreement (the "Equity Distribution Agreement") with BMO Capital Markets Corp. (the "U.S. Agent") and BMO Nesbitt Burns Inc. (the "Canadian Agent", and together with the U.S. Agent, the "Agents" and each an "Agent"), pursuant to which the Company may offer and sell, from time to time, up to an aggregate offering price of up to $200,000,000 of the Company's common shares (the "Common Shares") through the U.S. Agent, less any amounts sold in Canada through the Canadian Agent pursuant to the Concurrent Canadian Offering (as defined below); provided, however, that (i) in no event will the Company sell Common Shares in the Concurrent Canadian Offering for aggregate gross sales proceeds exceeding $50,000,000 (the "Canadian Cap") and (ii) in no event will the combined gross sales proceeds of the U.S. Offering (as defined below) and the Concurrent Canadian Offering exceed $200,000,000. The U.S. Agent may sell Common Shares only in the United States (the "U.S. Offering"), and the Canadian Agent may sell Common Shares only on marketplaces in Canada (the "Concurrent Canadian Offering"), subject to the Canadian Cap. The Equity Distribution Agreement replaces the equity distribution agreement, dated February 28, 2025, as amended, among the Company and the Agents, which terminated upon the Company's entry into the Equity Distribution Agreement. In the U.S. Offering, sales of Common Shares, if any, will be made by any method that is deemed to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act, including, but not limited to, sales made directly on The Nasdaq Global Select Market or any other trading market for the Common Shares in the United States or pursuant to any other sales method used by the U.S. Agent. In the Concurrent Canadian Offering, sales of Common Shares, if any, will be made in transactions that are deemed to be "at-the-market distribution

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 1.1*+ Equity Distribution Agreement, dated as of August 29, 2025, by and among Canopy Growth Corporation and BMO Capital Markets Corp. and BMO Nesbitt Burns Inc. 5.1 Opinion of Cassels Brock & Blackwell LLP 23.1 Consent of Cassels Brock & Blackwell LLP (included in Exhibit 5.1) 99.1 Press Release, dated August 29, 2025 104 Cover Page Interactive Data File (formatted in Inline XBRL document) * A non-material exhibit has been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of the omitted exhibit upon request by the SEC. + Portions of this exhibit have been omitted pursuant to Item 601(a)(6) of Regulation S-K.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CANOPY GROWTH CORPORATION Date: August 29, 2025 By: /s/ Thomas Stewart Thomas Stewart Interim Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.